Telavancin
HUM00095470
Approved small_molecule completed
Quick answer
Telavancin for End-Stage Renal Disease is a Approved program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- End-Stage Renal Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed